Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Always consult your healthcare provider before initiating or discontinuing any treatment
Pharmacokinetically, BPC-157 has a relatively short plasma half-life estimated at 10-15 minutes when administered parenterally, though its tissue-level effects persist far longer due to receptor-level interactions and growth factor cascading
Mason, et al
Currently, the primary treatment for myocardial infarction is opening blocked vessels to restore blood flow to the ischemic myocardium, which is called reperfusion
GHK-Cu is widely used in cosmetics (recognized INCI, present in over 100 products)
12,13 Decrease in Proinflammatory Cytokines A significant decrease in tumor necrosis factor-, IL-6, and interferon- has been observed with BPC-157
US$ 26.98
US$ 28.92
US$ 23.80
US$ 26.63
US$ 28.27
US$ 24.22
US$ 26.10
US$ 24.20
US$ 22.78
US$ 25.59
US$ 23.94
US$ 23.01
US$ 20.70
US$ 24.83
US$ 23.83
US$ 23.17
